Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | CYP4Cod1 | 0.0037 | 0.0173 | 0.0173 |
Trypanosoma cruzi | aurora B kinase, putative | 0.0116 | 0.146 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0037 | 0.0173 | 0.0173 |
Entamoeba histolytica | serine/threonine- protein kinase 6, putative | 0.0116 | 0.146 | 0.5 |
Trypanosoma brucei | aurora B kinase | 0.0116 | 0.146 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0294 | 0.4346 | 1 |
Trypanosoma brucei | cytochrome P450, putative | 0.0037 | 0.0173 | 0.0762 |
Brugia malayi | Cytochrome P450 family protein | 0.0037 | 0.0173 | 0.0107 |
Loa Loa (eye worm) | AUR protein kinase | 0.0116 | 0.146 | 0.146 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0116 | 0.146 | 0.5 |
Loa Loa (eye worm) | TTK protein kinase | 0.0294 | 0.4346 | 0.4346 |
Trichomonas vaginalis | AGC family protein kinase | 0.0116 | 0.146 | 0.286 |
Giardia lamblia | Kinase, TTK | 0.0294 | 0.4346 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0037 | 0.0173 | 0.0173 |
Echinococcus multilocularis | dual specificity serine:threonine tyrosine | 0.0294 | 0.4346 | 1 |
Brugia malayi | hypothetical protein | 0.0045 | 0.0304 | 0.0239 |
Leishmania major | protein kinase, putative | 0.0116 | 0.146 | 1 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0045 | 0.0304 | 0.1704 |
Loa Loa (eye worm) | hypothetical protein | 0.0045 | 0.0304 | 0.0304 |
Brugia malayi | Cytochrome P450 family protein | 0.0037 | 0.0173 | 0.0107 |
Loa Loa (eye worm) | AUR protein kinase | 0.0116 | 0.146 | 0.146 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0067 | 0.0067 |
Plasmodium falciparum | serine/threonine protein kinase, putative | 0.0116 | 0.146 | 1 |
Brugia malayi | serine/threonine kinase 12 | 0.0116 | 0.146 | 0.1403 |
Entamoeba histolytica | protein kinase, putative | 0.0116 | 0.146 | 0.5 |
Brugia malayi | serine/threonine-protein kinase 6 | 0.0116 | 0.146 | 0.1403 |
Trichomonas vaginalis | AGC family protein kinase | 0.0116 | 0.146 | 0.286 |
Entamoeba histolytica | protein kinase, putative | 0.0116 | 0.146 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0045 | 0.0304 | 0.1704 |
Entamoeba histolytica | serine/threonine- protein kinase 6 , putative | 0.0116 | 0.146 | 0.5 |
Leishmania major | cytochrome p450-like protein | 0.0037 | 0.0173 | 0.0762 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0037 | 0.0173 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0294 | 0.4346 | 1 |
Entamoeba histolytica | serine/threonine protein kinase 6, putative | 0.0116 | 0.146 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0116 | 0.146 | 0.286 |
Brugia malayi | serine/threonine protein kinase 6 | 0.0116 | 0.146 | 0.1403 |
Toxoplasma gondii | aurora kinase | 0.0116 | 0.146 | 1 |
Onchocerca volvulus | Dual specificity protein kinase TTK homolog | 0.0294 | 0.4346 | 1 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0037 | 0.0173 | 0.0762 |
Schistosoma mansoni | dual specificity serine/threonine tyrosine kinase | 0.0294 | 0.4346 | 1 |
Plasmodium vivax | serine/threonine protein kinase 6, putative | 0.0116 | 0.146 | 1 |
Loa Loa (eye worm) | AUR protein kinase | 0.0116 | 0.146 | 0.146 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0037 | 0.0173 | 0.0762 |
Brugia malayi | Protein kinase domain containing protein | 0.0294 | 0.4346 | 0.4308 |
Entamoeba histolytica | protein kinase , putative | 0.0116 | 0.146 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0116 | 0.146 | 0.286 |
Echinococcus granulosus | dual specificity serine:threonine tyrosine | 0.0294 | 0.4346 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0045 | 0.0304 | 0.1704 |
Loa Loa (eye worm) | hypothetical protein | 0.0641 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 15.8489 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.